SINGAPORE, May 1, 2023 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as well as complex hip replacements, including second-time hip replacements and replacements involving bone tumors and trauma. OSSIS provides rapid design and production of personalized implants that align with Zimmer Biomet's commitment to providing personalized experiences, with the goal of improving patient outcomes. This acquisition demonstrates Zimmer Biomet's commitment to advancing innovation in the medical technology industry and strengthens the Company's position as a global medical technology leader. Zimmer Biomet announced in July 2021 an agreement with OSSIS as the Company's Asia Pacific partner for patient-specific 3D-printed titanium hip joint replacements and other pelvi
SINGAPORE, March 30, 2023 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that ROSA HIP with ONE Planner Hip won the "Orthopaedic Product Innovation of the Year" at this year's Healthcare Asia Medtech Awards. As a precisely personalized robotic system, ROSA HIP enables direct anterior surgeons to evaluate and execute surgical plans based on real-time fluoroscopic feedback of each patient's unique anatomy, while seamlessly integrating with their surgical workflow.As part of ZBEdgeTM Dynamic IntelligenceTM, the system was developed by surgeons for surgeons as an accurate and efficient surgical assistant that also produces meaningful data. The ONE Planner Hip is an easy-to-use, pre-operative planner for primary total hip arthroplasty. Using the auto-plan mode, surgeons can create a preoperative plan within 5 minutes from standard x-ray images. ONE Planner Hip features an optional spinopelvic mobility as